Dapagliflozin effective but more bladder and breast cancers observed
28 June 2011
Sukaina Virji
Please Login to read the full article.
28 June 2011
Sukaina Virji
sukaina.virji@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- BMS and AZ to look at cardiprotective effect if dapagliflozin approved in diabetes
- US FDA panel rejects BMS/AstraZeneca diabetes drug on cancer, liver injury concerns
- Roche hands Phase II diabetes candidate back to Chugai amid 'reprioritisation'
- BMS, AstraZeneca win European nod for Onglyza with insulin in Type II diabetes
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
